FilingReader Intelligence
Fosun Pharma announces Rong Yang's resignation as senior vice president
May 20, 2025 at 05:09 PM UTC•By FilingReader AI
Shanghai Fosun Pharmaceutical Group (SSE:600196) announced that its board of directors has received a written resignation letter from Rong Yang, who will be stepping down from his role as Senior Vice President. The resignation, attributed to personal reasons, becomes effective on May 16, 2025. The board expressed its gratitude to Rong Yang for his contributions during his tenure as a senior management member of the company.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600196•Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime